Editorial: Repurposed Drugs Targeting Cancer Signaling Pathways: Dissecting New Mechanism of Action Through In Vitro and In Vivo Analyses

by Eduardo López-Urrutia, Teresita Padilla-Benavides, Carlos Pérez-Plasencia, Carlos Pérez-Plasencia, Alma D. Campos-Parra
Published 2021-10-01

Editorial: Repurposed Drugs Targeting Cancer Signaling Pathways: Clinical Insights to Improve Oncologic Therapies

by Carlos Pérez-Plasencia, Carlos Pérez-Plasencia, Teresita Padilla-Benavides, Eduardo López-Urrutia, Alma D. Campos-Parra
Published 2021-06-01

Interplay Between Autophagy and Wnt/β-Catenin Signaling in Cancer: Therapeutic Potential Through Drug Repositioning

by Carlos Pérez-Plasencia, Carlos Pérez-Plasencia, Eduardo López-Urrutia, Verónica García-Castillo, Samuel Trujano-Camacho, César López-Camarillo, Alma D. Campos-Parra
Published 2020-08-01

Crosstalk Between Long Non-coding RNAs, Micro-RNAs and mRNAs: Deciphering Molecular Mechanisms of Master Regulators in Cancer

by Eduardo López-Urrutia, Lilia P. Bustamante Montes, Diego Ladrón de Guevara Cervantes, Carlos Pérez-Plasencia, Carlos Pérez-Plasencia, Alma D. Campos-Parra
Published 2019-07-01

Long Non-Coding RNAs as New Master Regulators of Resistance to Systemic Treatments in Breast Cancer

by Alma D. Campos-Parra, Eduardo López-Urrutia, Luz Tonantzin Orozco Moreno, César López-Camarillo, Thuluz Meza-Menchaca, Gabriela Figueroa González, Lilia P. Bustamante Montes, Carlos Pérez-Plasencia
Published 2018-09-01

Negative Regulation of ULK1 by microRNA-106a in Autophagy Induced by a Triple Drug Combination in Colorectal Cancer Cells In Vitro

by Rebeca Salgado-García, Jossimar Coronel-Hernández, Izamary Delgado-Waldo, David Cantú de León, Verónica García-Castillo, Eduardo López-Urrutia, Ma. Concepción Gutiérrez-Ruiz, Carlos Pérez-Plasencia, Nadia Jacobo-Herrera
Published 2021-02-01

A Multi-Center Study of <i>BRCA1</i> and <i>BRCA2</i> Germline Mutations in Mexican-Mestizo Breast Cancer Families Reveals Mutations Unreported in Latin American Population

by Oliver Millan Catalan, Alma D. Campos-Parra, Rafael Vázquez-Romo, David Cantú de León, Nadia Jacobo-Herrera, Fermín Morales-González, César López-Camarillo, Mauricio Rodríguez-Dorantes, Eduardo López-Urrutia, Carlos Pérez-Plasencia
Published 2019-08-01

MiR-26a downregulates retinoblastoma in colorectal cancer

by Eduardo López-Urrutia, Jossimar Coronel-Hernández, Verónica García-Castillo, Carlos Contreras-Romero, Antonio Martínez-Gutierrez, Diana Estrada-Galicia, Luis Ignacio Terrazas, César López-Camarillo, Hector Maldonado-Martínez, Nadia Jacobo-Herrera, Carlos Pérez-Plasencia
Published 2017-04-01

Transcript Profiling Distinguishes Complete Treatment Responders With Locally Advanced Cervical Cancer

by Jorge Fernandez-Retana, Federico Lasa-Gonsebatt, Eduardo Lopez-Urrutia, Jaime Coronel-Martínez, David Cantu De Leon, Nadia Jacobo-Herrera, Oscar Peralta-Zaragoza, Delia Perez-Montiel, Nancy Reynoso-Noveron, Rafael Vazquez-Romo, Carlos Perez-Plasencia
Published 2015-04-01

MicroRNAs in Cervical Cancer: Evidences for a miRNA Profile Deregulated by HPV and Its Impact on Radio-Resistance

by Abraham Pedroza-Torres, Eduardo López-Urrutia, Verónica García-Castillo, Nadia Jacobo-Herrera, Luis A. Herrera, Oscar Peralta-Zaragoza, César López-Camarillo, David Cantú De Leon, Jorge Fernández-Retana, Jorge F. Cerna-Cortés, Carlos Pérez-Plasencia
Published 2014-05-01

Cell migration and proliferation are regulated by miR-26a in colorectal cancer via the PTEN–AKT axis

by Jossimar Coronel-Hernández, Eduardo López-Urrutia, Carlos Contreras-Romero, Izamary Delgado-Waldo, Gabriela Figueroa-González, Alma D. Campos-Parra, Rebeca Salgado-García, Antonio Martínez-Gutierrez, Miguel Rodríguez-Morales, Nadia Jacobo-Herrera, Luis Ignacio Terrazas, Abraham Silva-Carmona, César López-Camarillo, Carlos Pérez-Plasencia
Published 2019-04-01